imipramine has been researched along with palmitic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, BB; Lu, YN; Xu, M | 1 |
| Chowdhury, N; Huang, Y; Li, Y; Lopes-Virella, M; Lu, Z; Syn, WK; Yilmaz, Ö; Yu, H | 1 |
2 other study(ies) available for imipramine and palmitic acid
| Article | Year |
|---|---|
Acid sphingomyelinase downregulation alleviates vascular endothelial leptin resistance in rats.
Topics: Amitriptyline; Animals; Biocatalysis; Cells, Cultured; Disease Models, Animal; Down-Regulation; Endothelial Cells; Enzyme Inhibitors; Imipramine; Leptin; Male; Palmitic Acid; Rats; Rats, Sprague-Dawley; Receptors, Leptin; Sphingomyelin Phosphodiesterase | 2020 |
The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome.
Topics: Animals; Ceramides; Diet, High-Fat; Imipramine; Inflammation; Insulin Resistance; Lipopolysaccharides; Liver; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Periodontitis; Sphingolipids | 2023 |